Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Xenon Pharmaceuticals Inc. (XENE) had Operating Cash Flow per Share of $-0.78 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.50M |
|
$-65.05M |
|
-- |
|
$7.50M |
|
$80.24M |
|
$-72.74M |
|
$8.12M |
|
$-64.62M |
|
$-64.62M |
|
$-65.05M |
|
$-65.05M |
|
$-65.05M |
|
$-65.05M |
|
$-72.74M |
|
$-72.08M |
|
78.69M |
|
78.69M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$565.54M |
|
$9.70M |
|
$177.74M |
|
$743.28M |
|
$32.03M |
|
-- |
|
$7.29M |
|
$39.32M |
|
$703.96M |
|
$703.96M |
|
$703.96M |
|
76.59M |
|
| Cash Flow Statement Financials | |
$-61.65M |
|
$34.51M |
|
$1.15M |
|
$142.71M |
|
$116.66M |
|
$-26.05M |
|
$12.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-969.84% |
|
-969.84% |
|
-- |
|
-861.60% |
|
-867.29% |
|
$-61.70M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.87 |
|
103.79 |
|
-9.24% |
|
-9.24% |
|
-8.75% |
|
-9.24% |
|
$9.19 |
|
$-0.78 |
|
|
Operating Cash Flow per Share |
$-0.78 |